A major obstacle in the treatment of malignant melanoma is its resistance to classical chemotherapy and radiotherapy, which may be due, in part, to a natural resistance to apoptosis [21] attributed to high levels of anti-apoptotic Bcl2 proteins [22]. The gene discussed is BCL2; the disease is melanoma.